BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 20032256)

  • 1. Evaluation of diagnostic tests for Clostridium difficile infection.
    Swindells J; Brenwald N; Reading N; Oppenheim B
    J Clin Microbiol; 2010 Feb; 48(2):606-8. PubMed ID: 20032256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of BD GeneOhm Cdiff real-time PCR assay with a two-step algorithm and a toxin A/B enzyme-linked immunosorbent assay for diagnosis of toxigenic Clostridium difficile infection.
    Kvach EJ; Ferguson D; Riska PF; Landry ML
    J Clin Microbiol; 2010 Jan; 48(1):109-14. PubMed ID: 19864479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C. Diff Quik Chek complete enzyme immunoassay provides a reliable first-line method for detection of Clostridium difficile in stool specimens.
    Quinn CD; Sefers SE; Babiker W; He Y; Alcabasa R; Stratton CW; Carroll KC; Tang YW
    J Clin Microbiol; 2010 Feb; 48(2):603-5. PubMed ID: 19955275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of tcdB real-time PCR in a three-step diagnostic algorithm for detection of toxigenic Clostridium difficile.
    Larson AM; Fung AM; Fang FC
    J Clin Microbiol; 2010 Jan; 48(1):124-30. PubMed ID: 19923482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is a two-step glutamate dehyrogenase antigen-cytotoxicity neutralization assay algorithm superior to the premier toxin A and B enzyme immunoassay for laboratory detection of Clostridium difficile?
    Gilligan PH
    J Clin Microbiol; 2008 Apr; 46(4):1523-5. PubMed ID: 18256226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between Clostridium difficile bacterial load, commercial real-time PCR cycle thresholds, and results of diagnostic tests based on enzyme immunoassay and cell culture cytotoxicity assay.
    Dionne LL; Raymond F; Corbeil J; Longtin J; Gervais P; Longtin Y
    J Clin Microbiol; 2013 Nov; 51(11):3624-30. PubMed ID: 23966497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of a commercial multiplex real-time PCR to the cell cytotoxicity neutralization assay for diagnosis of clostridium difficile infections.
    Huang H; Weintraub A; Fang H; Nord CE
    J Clin Microbiol; 2009 Nov; 47(11):3729-31. PubMed ID: 19741082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of a commercial real-time PCR assay for tcdB detection to a cell culture cytotoxicity assay and toxigenic culture for direct detection of toxin-producing Clostridium difficile in clinical samples.
    Stamper PD; Alcabasa R; Aird D; Babiker W; Wehrlin J; Ikpeama I; Carroll KC
    J Clin Microbiol; 2009 Feb; 47(2):373-8. PubMed ID: 19073875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of real-time PCR for detection of the tcdC gene with four toxin immunoassays and culture in diagnosis of Clostridium difficile infection.
    Sloan LM; Duresko BJ; Gustafson DR; Rosenblatt JE
    J Clin Microbiol; 2008 Jun; 46(6):1996-2001. PubMed ID: 18434563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonutility of repeat laboratory testing for detection of Clostridium difficile by use of PCR or enzyme immunoassay.
    Aichinger E; Schleck CD; Harmsen WS; Nyre LM; Patel R
    J Clin Microbiol; 2008 Nov; 46(11):3795-7. PubMed ID: 18784320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid detection of toxigenic strains of Clostridium difficile in diarrheal stools by real-time PCR.
    Barbut F; Braun M; Burghoffer B; Lalande V; Eckert C
    J Clin Microbiol; 2009 Apr; 47(4):1276-7. PubMed ID: 19244461
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of a new commercial TaqMan PCR assay for direct detection of the clostridium difficile toxin B gene in clinical stool specimens.
    Stamper PD; Babiker W; Alcabasa R; Aird D; Wehrlin J; Ikpeama I; Gluck L; Carroll KC
    J Clin Microbiol; 2009 Dec; 47(12):3846-50. PubMed ID: 19846637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clostridium difficile testing in the clinical laboratory by use of multiple testing algorithms.
    Novak-Weekley SM; Marlowe EM; Miller JM; Cumpio J; Nomura JH; Vance PH; Weissfeld A
    J Clin Microbiol; 2010 Mar; 48(3):889-93. PubMed ID: 20071552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of six commercial assays for the rapid detection of Clostridium difficile toxin and/or antigen in stool specimens.
    Vanpoucke H; De Baere T; Claeys G; Vaneechoutte M; Verschraegen G
    Clin Microbiol Infect; 2001 Feb; 7(2):55-64. PubMed ID: 11298143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of an automated rapid diagnostic test for detection of Clostridium difficile.
    Tojo M; Nagamatsu M; Hayakawa K; Mezaki K; Kirikae T; Ohmagari N
    PLoS One; 2014; 9(8):e106102. PubMed ID: 25170836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of three commercial methods for rapid detection of Clostridium difficile toxins A and B from fecal specimens.
    Alcalá L; Sánchez-Cambronero L; Catalán MP; Sánchez-Somolinos M; Peláez MT; Marín M; Bouza E
    J Clin Microbiol; 2008 Nov; 46(11):3833-5. PubMed ID: 18784313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a rapid enzyme immunoassay for Clostridium difficile toxin A and its use in the diagnosis of C. difficile-associated disease.
    DiPersio JR; Varga FJ; Conwell DL; Kraft JA; Kozak KJ; Willis DH
    J Clin Microbiol; 1991 Dec; 29(12):2724-30. PubMed ID: 1757540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Algorithm combining toxin immunoassay and stool culture for diagnosis of Clostridium difficile infection.
    Shin BM; Kuak EY; Lee EJ; Songer JG
    J Clin Microbiol; 2009 Sep; 47(9):2952-6. PubMed ID: 19625481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid and reliable diagnostic algorithm for detection of Clostridium difficile.
    Fenner L; Widmer AF; Goy G; Rudin S; Frei R
    J Clin Microbiol; 2008 Jan; 46(1):328-30. PubMed ID: 18032627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in the use of laboratory tests for the diagnosis of Clostridium difficile infection and association with incidence rates in Quebec, Canada, 2010-2014.
    Bogaty C; Lévesque S; Garenc C; Frenette C; Bolduc D; Galarneau LA; Lalancette C; Loo V; Tremblay C; Trudeau M; Vachon J; Dionne M; Villeneuve J; Longtin J; Longtin Y;
    Am J Infect Control; 2017 Sep; 45(9):964-968. PubMed ID: 28549882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.